Systems pharmacology approaches in herbal medicine research: a brief review

키워드

참고문헌 (115)

1. Zhao X, "A novel drug discovery strategy inspired by traditional medicine philosophies", Science, 347, pp.S38~ (2015)
2. Corson TW, "Molecular under-standing and modern application of traditional medicines : triumphs and trials", Cell, 130, pp.769~774 (2007)
3. Stancak B, "Does the left atrial dimension predict the short-term effect of electric cardioversion?", Vnitr Lek, 36, pp.753~758 (1990)
4. Fernandes F, "Multi-target neuroprotective effects of herbal medicines for Alzheimer’s disease", J Ethnopharmacol, 290, pp.115107~ (2022)
5. Zhao S, "Systems pharmacology : network analysis to identify multiscale mechanisms of drug action", Annu Rev Pharmacol Toxicol, 52, pp.505~521 (2012)
6. Hopkins AL, "Network pharmacology : the next paradigm in drug discovery", Nat Chem Biol, 4, pp.682~690 (2008)
7. Kibble M, "Network pharmacology applications to map the unexplored target space and therapeutic potential of natural products", Nat Prod Rep, 32, pp.1249~1266 (2015)
8. Huang C, "Systems pharmacology in drug discovery and therapeutic insight for herbal medicines", Brief Bioinform, 15, pp.710~733 (2014)
9. Casas AI, "From single drug targets to synergistic network pharmacology in ischemic stroke", Proc Natl Acad Sci U S A, 116, pp.7129~7136 (2019)
10. Wang X, "PRODeepSyn : predicting anticancer synergistic drug combinations by embedding cell lines with protein-protein interaction network", Brief Bioinform, 23, pp.bbab587~ (2022)
11. Xu Z, "Modernization : one step at a time", Nature, 480, pp.S90~ (2011)
12. Li P, "TMNP : a transcriptome-based multi-scale network pharmacology platform for herbal medicine", Brief Bioinform, 23, pp.bbab542~ (2022)
13. Lamb J, "The connectivity map : using gene-expression signatures to connect small molecules, genes, and disease", Science, 313, pp.1929~1935 (2006)
14. Subramanian A, "A next generation connectivity map : L1000 platform and the first 1, 000, 000 profiles", Cell, 171, pp.1437~1452 (2017)
15. 권옥선, "In silico drug repositioning: from large-scale transcriptome data to therapeutics", Archives of Pharmacal Research, 42(10), pp.879~889 (2019), 대한약학회[DOI]
16. Jiang H, "The advantages of connectivity map applied in traditional Chinese medicine", Front Pharmacol, 12, pp.474267~ (2021)
17. Lv C, "The gene expression profiles in response to 102 traditional Chinese medicine(TCM)components : a general template for research on TCMs", Sci Rep, 7, pp.352~ (2017)
18. Li P, "Detection of vasodilators from herbal components by a transcriptomebased functional gene module reference approach", Front Pharmacol, 10, pp.1144~ (2019)
19. Wang L, "Functional gene module-based identification of phillyrin as an anticardiac fibrosis agent", Front Pharmacol, 11, pp.1077~ (2020)
20. Fang S, "HERB : a high-throughput experiment-and reference-guided database of traditional Chinese medicine", Nucleic Acids Res, 49, pp.D1197~ (2021)
21. Huang L, "TCMID 2. 0 : a comprehensive resource for TCM", Nucleic Acids Res, 46, pp.D1117~ (2018)
22. Ru J, "TCMSP : a database of systems pharmacology for drug discovery from herbal medicines", J Cheminform, 6, pp.13~ (2014)
23. Liu Z, "BATMAN-TCM : a bioinformatics analysis tool for molecular mechANism of traditional Chinese medicine", Sci Rep, 6, pp.21146~ (2016)
24. Wu Y, "SymMap : an integrative database of traditional Chinese medicine enhanced by symptom mapping", Nucleic Acids Res, 47, pp.D1110~ (2019)
25. Kim S, "PubChem in 2021 : new data content and improved web interfaces", Nucleic Acids Res, 49, pp.D1388~ (2021)
26. Daina A, "SwissADME : a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules", Sci Rep, 7, pp.42717~ (2017)
27. Daina A, "SwissTargetPrediction : updated data and new features for efficient prediction of protein targets of small molecules", Nucleic Acids Res, 47, pp.W357~ (2019)
28. Szklarczyk D, "STITCH 5 : augmenting protein-chemical interaction networks with tissue and affinity data", Nucleic Acids Res, 44, pp.D380~D384 (2016)
29. Chen X, "TTD : therapeutic target database", Nucleic Acids Res, 30, pp.412~415 (2002)
30. Yu H, "A systematic prediction of multiple drug-target interactions from chemical, genomic, and pharmacological data", PLoS One, 7, pp.e37608~ (2012)
31. Zhao S, "Network-based relating pharmacological and genomic spaces for drug target identification", PLoS One, 5, pp.e11764~ (2010)
32. UniProt C, "UniProt : the universal protein knowledgebase in 2021", Nucleic Acids Res, 49, pp.D480~ (2021)
33. Stelzer G, "The genecards suite : from gene data mining to disease genome sequence analyses", Curr Protoc Bioinformatics, 54, pp.1~ (2016)
34. Kanehisa M, "KEGG : new perspectives on genomes, pathways, diseases and drugs", Nucleic Acids Res, 45, pp.D353~ (2017)
35. Jassal B, "The reactome pathway knowledgebase", Nucleic Acids Res, 48, pp.D498~ (2020)
36. The Gene Ontology Consortium, "The Gene Ontology Resource : 20 years and still GOing strong", Nucleic Acids Res, 47, pp.D330~ (2019)
37. Subramanian A, "Gene set enrichment analysis : a knowledge-based approach for interpreting genome-wide expression profiles", Proc Natl Acad Sci U S A, 102, pp.15545~15550 (2005)
38. Szklarczyk D, "The STRING database in 2021 : customizable protein-protein networks, and functional characterization of user-uploaded gene", measurement sets, 2021, pp.49, D605~
39. Keshava Prasad TS, "Human Protein Reference Database--2009 update", Nucleic Acids Res, 37, pp.D767~D772 (2009)
40. Athanasios A, "Protein-Protein Interaction(PPI)Network : recent advances in drug discovery", Curr Drug Metab, 18, pp.5~10 (2017)
41. Pinero J, "The DisGeNET knowledge platform for disease genomics : 2019 update", Nucleic Acids Res, 48, pp.D845~ (2020)
42. Amberger JS, "OMIM. org : leveraging knowledge across phenotypegene relationships", Nucleic Acids Res, 47, pp.D1038~ (2019)
43. Kohler S, "The Human Phenotype Ontology in 2021", Nucleic Acids Res, 49, pp.D1207~ (2021)
44. Dancey JE, "Strategies for optimizing combinations of molecularly targeted anticancer agents", Nat Rev Drug Discov, 5, pp.649~659 (2006)
45. Reddy AS, "Polypharmacology : drug discovery for the future", Expert Rev Clin Pharmacol, 6, pp.41~47 (2013)
46. Li S, "Network target for screening synergistic drug combinations with application to traditional Chinese medicine", BMC Syst Biol, 5, pp.S10~ (2011)
47. Wang X, "A systems biology approach to uncovering pharmacological synergy in herbal medicines with applications to cardiovascular disease", Evid Based Complement Alternat Med, 2012, pp.519031~ (2012)
48. Li P, "Transcriptome inference and systems approaches to polypharmacology and drug discovery in herbal medicine", J Ethnopharmacol, 195, pp.127~136 (2017)
49. Wang N, "Herb target prediction based on representation learning of symptom related heterogeneous network", Comput Struct Biotechnol J, 17, pp.282~290 (2019)
50. Zhao W, "HGNA-HTI: Heterogeneous graph neural network with attention mechanism for prediction of herb-target interactions", IEEE International Conference on Bioinformatics and Biomedicine (BIBM), pp.3949~3956 (2021)
51. Keum J, "Prediction of compound-target interactions of natural products using large-scale drug and protein information", BMC Bioinformatics, 17(Suppl 6), pp.219~ (2016)
52. Grover A, "node2vec : scalable feature learning for networks", KDD, 2016, pp.855~864 (2016)
53. Bleakley K, "Supervised prediction of drug-target interactions using bipartite local models", Bioinformatics, 25, pp.2397~2403 (2009)
54. Xu X, "New concepts and approaches for drug discovery based on traditional Chinese medicine", Drug Discov Today Technol, 3, pp.247~253 (2006)
55. Yoo S, "Phenotype-oriented network analysis for discovering pharmacological effects of natural compounds", Sci Rep, 8, pp.11667~ (2018)
56. Yoo S, "A deep learningbased approach for identifying the medicinal uses of plant-derived natural compounds", Front Pharmacol, 11, pp.584875~ (2020)
57. Yoo S, "Discovering health benefits of phytochemicals with integrated analysis of the molecular network, chemical properties and ethnopharmacological evidence", Nutrients, 10, pp.1042~ (2018)
58. Kim E, "Drug repositioning of herbal compounds via a machine-learning approach", BMC Bioinformatics, 20, pp.247~ (2019)
59. Gottlieb A, "PREDICT : a method for inferring novel drug indications with application to personalized medicine", Mol Syst Biol, 7, pp.496~ (2011)
60. Li P, "Systems pharmacology strategies for drug discovery and combination with applications to cardiovascular diseases", J Ethnopharmacol, 151, pp.93~107 (2014)
61. Cases M, "A chemogenomic approach to drug discovery : focus on cardiovascular diseases", Drug Discov Today, 14, pp.479~485 (2009)
62. Kong DX, "Where is the hope for drug discovery?", Let history tell the future. Drug Discov Today, 14, pp.115~119 (2009)
63. Wang Y, "Network-based modeling of herb combinations in traditional Chinese medicine", Brief Bioinform, 22, pp.bbab106~ (2021)
64. Wishart DS, "DrugBank 5. 0 : a major update to the DrugBank database for 2018", Nucleic Acids Res, 46, pp.D1074~ (2018)
65. Thorn CF, "PharmGKB : the pharmacogenetics and pharmacogenomics knowledge base", Methods Mol Biol, 311, pp.179~191 (2005)
66. Ye H, "HIT : linking herbal active ingredients to targets", Nucleic Acids Res, 39, pp.D1055~ (2011)
67. Kuhn M, "The SIDER database of drugs and side effects", Nucleic Acids Res, 44, pp.D1075~ (2016)
68. Rappaport N, "MalaCards : an amalgamated human disease compendium with diverse clinical and genetic annotation and structured search", Nucleic Acids Res, 45, pp.D877~ (2017)
69. Kilicoglu H, "SemMedDB : a PubMed-scale repository of biomedical semantic predications", Bioinformatics, 28, pp.3158~3160 (2012)
70. Zhou X, "Human symptoms-disease network", Nat Commun, 5, pp.4212~ (2014)
71. Hu Z, "Heterogeneous graph transformer", Proceedings of The Web Conference, 2020, pp.2704~2710 (2020)
72. Yang K, "Heterogeneous network propagation for herb target identification", BMC Med Inform Decis Mak, 18, pp.17~ (2018)
73. Li B, "YaTCM : yet another traditional Chinese medicine database for drug discovery", Comput Struct Biotechnol J, 16, pp.600~610 (2018)
74. Xu HY, "Exploiture and application of an internet-based computation platform for integrative pharmacology of traditional chinese medicine", Zhongguo Zhong Yao Za Zhi, 42, pp.3633~3638 (2017)
75. Chen X, "Database of traditional Chinese medicine and its application to studies of mechanism and to prescription validation", Br J Pharmacol, 149, pp.1092~1103 (2006)
76. Chen CY, "TCM Database@Taiwan : the world’s largest traditional Chinese medicine database for drug screening in silico", PLoS One, 6, pp.e15939~ (2011)
77. Yoo S, "A data-driven approach for identifying medicinal combinations of natural products", IEEE Access, 6, pp.58106~58118 (2018)
78. Davis AP, "The Comparative Toxicogenomics Database : update 2011", Nucleic Acids Res, 39, pp.D1067~D1072 (2011)
79. Gunther S, "SuperTarget and Matador : resources for exploring drug-target relationships", Nucleic Acids Res, 36, pp.D919~D922 (2008)
80. Chatr-Aryamontri A, "The BioGRID interaction database : 2015 update", Nucleic Acids Res, 43, pp.D470~D478 (2015)
81. Tatonetti NP, "Data-driven prediction of drug effects and interactions", Sci Transl Med, 4, pp.125~ (2012)
82. UniProt C, "UniProt : a hub for protein information", Nucleic Acids Res, 43, pp.D204~D212 (2015)
83. Griffith M, "DGIdb : mining the druggable genome", Nat Methods, 10, pp.1209~1210 (2013)
84. Robinson PN, "The Human Phenotype Ontology : a tool for annotating and analyzing human hereditary disease", Am J Hum Genet, 83, pp.610~615 (2008)
85. Pinero J, "DisGeNET : a comprehensive platform integrating information on human disease-associated genes and variants", Nucleic Acids Res, 45, pp.D833~ (2017)
86. Liu T, "BindingDB : a web-accessible database of experimentally determined protein-ligand binding affinities", Nucleic Acids Res, 35, pp.D198~ (2007)
87. Cheng F, "Networkbased prediction of drug combinations", Nat Commun, 10, pp.1197~ (2019)
88. Chavan P, "DNA microarrays in herbal drug research", Evid Based Complement Alternat Med, 3, pp.447~457 (2006)
89. Hwang YH, "Food-and gender-dependent pharmacokinetics of paeoniflorin after oral administration with Samul-tang in rats", J Ethnopharmacol, 142, pp.161~167 (2012)
90. Ryu JH, "The effects of Sa-Mul-Tang, a traditional Chinese medicine, on phenylhydrazineinduced anemic rats", J Appl Phamacol, 9, pp.109~114 (2001)
91. Wen Z, "Discovery of molecular mechanisms of traditional Chinese medicinal formula Si-Wu-Tang using gene expression microarray and connectivity map", PLoS One, 6, pp.e18278~ (2011)
92. Liu M, "Transcriptional profiling of Chinese medicinal formula Si-Wu-Tang on breast cancer cells reveals phytoestrogenic activity", BMC Complement Altern Med, 13, pp.11~ (2013)
93. Fang Z, "Evaluating the pharmacological mechanism of Chinese medicine Si-Wu-Tang through multi-level data integration", PLoS One, 8, pp.e72334~ (2013)
94. Huang GC, "Elucidation of the Effects of Si-Wu Tang on menstrual disorder patterns through activation of aromatase and antioxidation", Evid Based Complement Alternat Med, 2019, pp.4761651~ (2019)
95. Kim J, "Samul-tang ameliorates oocyte damage due to cyclophosphamide-induced chronic ovarian dysfunction in mice", Sci Rep, 10, pp.21925~ (2020)
96. Kim J, "Effect of samul-tang on female fertility via RAS signaling pathway in ovaries of aged mice", Aging(Albany NY), 13, pp.14829~14842 (2021)
97. Kim Jihyun, "Restoration of miR-223-3p expression in aged mouse uteri with Samul-tang administration", Integrative Medicine Research, 11(2), pp.1~7 (2022), 한국한의학연구원[DOI]
98. Kim J, "Phytochemicals in ischemic stroke", Neuromolecular Med, 18, pp.283~305 (2016)
99. Duan X, "High throughput mRNA sequencing reveals potential therapeutic targets of Tao-Hong-Si-Wu decoction in experimental middle cerebral artery occlusion", Front Pharmacol, 9, pp.1570~ (2018)
100. Qu Z, "Identification of candidate anti-cancer molecular mechanisms of compound Kushen injection using functional genomics", Oncotarget, 7, pp.66003~66019 (2016)
101. Shen H, "Understanding the mechanistic contribution of herbal extracts in compound Kushen injection with transcriptome analysis", Front Oncol, 9, pp.632~ (2019)
102. Nourmohammadi S, "Effect of compound Kushen injection, a natural compound mixture, and its identified chemical components on migration and invasion of colon, brain, and breast cancer cell lines", Front Oncol, 9, pp.314~ (2019)
103. Cui J, "The effect of compound kushen injection on cancer cells : integrated identification of candidate molecular mechanisms", PLoS One, 15, pp.e0236395~ (2020)
104. Zhang L, "Protective roles of pulmonary rehabilitation mixture in experimental pulmonary fibrosis in vitro and in vivo", Braz J Med Biol Res, 48, pp.545~552 (2015)
105. Li H, "Feifukang ameliorates pulmonary fibrosis by inhibiting JAK-STAT signaling pathway", BMC Complement Altern Med, 18, pp.234~ (2018)
106. Tan YQ, "Efficacy, chemical constituents, and pharmacological actions of Radix Paeoniae Rubra and Radix Paeoniae Alba", Front Pharmacol, 11, pp.1054~ (2020)
107. Baek SJ, "Identification of a novel anticancer mechanism of Paeoniae Radix extracts based on systematic transcriptome analysis", Biomed Pharmacother, 148, pp.112748~ (2022)
108. Chen B, "Harnessing big ‘omics’ data and AI for drug discovery in hepatocellular carcinoma", Nat Rev Gastroenterol Hepatol, 17, pp.238~251 (2020)
109. Shijian Luo, "Connectivity map identifies luteolin as a treatment option of ischemic stroke by inhibiting MMP9 and activation of the PI3K", Akt signaling pathway, 2019, pp.51, 1~11[DOI]
110. Liu J, "Treatment of obesity with celastrol", Cell, 161, pp.999~1011 (2015)
111. Wang TY, "Bioactive flavonoids in medicinal plants : structure, activity and biological fate", Asian J Pharm Sci, 13, pp.12~23 (2018)
112. Zhu Q, "Targeted exploration and analysis of large cross-platform human transcriptomic compendia", Nat Methods, 12, pp.211~214 (2015)
113. Lee JJ, "Anti-inflammatory activity of the decoction of Forsythia suspensa(Thunb. )Vahl is related to Nrf2 and A20", J Ethnopharmacol, 227, pp.97~104 (2018)
114. Belyaeva A, "Causal network models of SARS-CoV-2 expression and aging to identify candidates for drug repurposing", Nat Commun, 12, pp.1024~ (2021)
115. Budhraja A, "Molecular signature of postmortem lung tissue from COVID-19patients suggests distinct trajectories driving mortality", Dis Model Mech, 15, pp.dmm049572~ (2022)

관련 논문AI추천